市场调查报告书
商品编码
1321040
数字生物製造市场 - 2017-2027 年全球行业规模、份额、趋势、机会和预测,按技术、按应用、最终用户、公司和地区细分Digital Biomanufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology, By Application, By End User, By Company and By Region |
预计全球数字生物製造市场在 2023-2027 年预测期内将出现令人印象深刻的增长。主要因素包括各行业自动化进程的不断提高、医疗保健行业向数字化和生物製造的转变以及技术的广泛发展,这些都抑制了市场的增长。数字生物製造是指在製造过程中使用数字技术,例如计算机辅助设计(CAD)和计算机辅助加工(CAM)。这些技术的应用有助于提高质量、功效和安全标准。支持市场增长的其他因素包括广泛的研究和开发、对生物製剂的需求不断增加、对减少错误、成本和时间的日益重视、私营和公共部门的各种投资、公司之间合作的数量不断增加、和合同製造组织,特别是在新兴国家。
在过去的几年里,各公司所采用的过时方法面临着许多挑战。因此,一些公司正在选择自动化流程。自动化不断融入工作环境正在推动市场的增长。这有助于提高大量工业流程的效率和高质量以及生产率。自动化在致力于开发新的治疗干预措施(例如药物开发、细胞疗法等)的应用研究实验室中也发挥着重要作用。例如,Arctoris 是一家完全自动化的平台公司,它使用机器人、人工智能和区块链来生成强大、可靠、可重复的数据,并促进药物发现中更好的决策。它还与药物发现资产的内部渠道合作,并与全球生物技术和製药公司以及学术中心建立了有效的合作伙伴关係。
製药和生物技术公司以及研究实验室的工具和技术的快速进步正在促进全球数字生物製造市场的增长。人工智能、数字孪生、智能工作流程和机器人等数字工具集成到设备中,可以更轻鬆地优化製造流程。由于对生产力交付和生物治疗营销的高需求,数字製造流程的采用有所增加。此外,技术驱动型行业(主要是一次性技术和信息技术公司)之间的併购有所增加。私人市场参与者、行业政府和学术组织之间越来越多的合作和伙伴关係也限制了现代生物製造技术的采用。从而反过来加强市场的增长。例如,Cytiva 采用了罗克韦尔自动化 PlantPAx 系统,并利用自己的 Unicorn 软件来实现其生物工艺设备的自动化。数据可通过 MES 应用程序访问,并可合併以纳入电子批次记录、调度等。
全球数字生物製造市场分为技术、应用、最终用户和公司。根据技术,市场分为人工智能和物联网解决方案、过程分析技术、数据分析软件等。根据应用,市场分为生物製造过程自动化和控制、生物过程优化和过程分析以及柔性製造。根据最终用户,市场分为生物技术和製药公司、学术和研究机构等。就国家而言,由于美国广泛的技术发展,预计在预测期内美国将成为一个利润丰厚的市场。
Agilent Technologies, Inc.、Danaher Corporation、Donaldson Company, Inc.、SAP SE、Honeywell International Inc.、Emerson Electric Company、Siemens、Healthineers AG、Atos SE、GE Healthcare 和 e-Matica srl 是运营中的一些领先公司在市场上。
根据给定的市场数据,TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项:
The global digital biomanufacturing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the rising automation process in various industries, the shift toward digitalization and biomanufacturing in the healthcare industry, and extensive development in technology, which are curbing the market'smarket's growth. Digital Biomanufacturing refers to the use of digital technologies in manufacturing processes, for instance, computer-aided design (CAD) and computer-assisted machining (CAM). The application of these technologies assists in improving quality, efficacy, and safety standards. The other factors supporting the market'smarket's growth are the extensive research and development, increasing demand for biologics, rising emphasis on reduction in errors, cost, and time, various investments by private as well public sectors, the growing number of collaborations between companies, and contract manufacturing organizations, particularly in emerging countries.
Over the past few years, numerous challenges have been faced by the outdated methods practiced by various companies. Therefore, several companies are opting for automation processes. The ongoing integration of automation into work environments is bolstering the growth of the market. This aids the efficiency and high quality of a massive array of industrial processes and production rates. Automation also plays an essential role in laboratories that deals with applied research that strives to develop new therapeutic interventions such as pharmaceutical developments, cell-based therapies, and others. For instance, Arctoris is a fully automated platform company that uses robotics, Artificial Intelligence, and blockchain to produce robust, reliable, reproducible data and facilitate better decisions in drug discovery. It also works with an internal pipeline of drug discovery assets and effective partnerships with biotech and pharma firms, as well as academic centers, globally.
Rapid advancements in the tools and techniques in pharmaceutical and biotechnology companies and research laboratories are augmenting the growth of the digital biomanufacturing market globally. Digital tools such as AI, digital twins, smart workflows, and robotics are integrated into equipment to make it easier to optimize the manufacturing process. Owing to the high demand for productivity delivery and marketing biotherapeutics, there is a rise in the adoption of digital manufacturing processes. Furthermore, there is a rise in mergers and acquisitions among technology-driven industries, mainly single-use technologies and information technology firms. A rising number of collaborations and partnerships between private market players, industry-government, and academic organizations are also curbing the adoption of modern technologies for biomanufacturing. Thus, in turn, strengthening the growth of the market. For instance, Cytiva adopted the Rockwell Automation PlantPAx system and utilized its own Unicorn software to automate its bioprocess equipment. Data is made accessible through MES applications and can be combined to incorporate electronic batch records, scheduling, and more.
The global digital biomanufacturing market is segmented into technology, application, end-user, and company. Based on technology, the market is segmented into AI & IOMT solutions, process analytical technologies, data analytics software, and others. Based on application, the market is segmented into biomanufacturing process automation and control, bioprocess optimization and process analytics, and flexible manufacturing. Based on end users, the market is divided into biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the extensive technology development in the country.
Agilent Technologies, Inc., Danaher Corporation, Donaldson Company, Inc., SAP SE, Honeywell International Inc., Emerson Electric Company, Siemens, Healthineers AG, Atos SE, GE Healthcare, and e-Matica srl are some of the leading companies operating in the market.
In this report, global digital biomanufacturing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Digital Biomanufacturing Market
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: